We are talking about products which saves lives not the normal antibiotics or pain killers. The MSB products in the pipeline are potentially billion dollar revenue earners. Hence your valuation is grossly understated. You add in patents and goodwill over the years and potential profits, we are looking at figures that are pretty healthy. The aGVHD is a small start and the there are bigger and better things to come. What we need now is a partnership and I do hope hope that Management is now in the process of signing the dotted lines.
Future Company Valuations in general & MSB, page-8
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.49 |
Change
0.140(10.4%) |
Mkt cap ! $1.701B | |||
| Open | High | Low | Value | Volume |
| $1.37 | $1.54 | $1.37 | $23.10M | 15.82M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 24758 | $1.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.49 | 73626 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |